MELOXICAM TABLETS

The Defense Logistics Agency awarded a delivery order under the base contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 2 bulk units of Meloxicam Tablets with NSN 6505015413243 at a unit price of $45.00, resulting in a total contract value of $90.00. This transaction is classified as a commercial item acquisition governed by FAR Part 12 and issued under an Economically Disadvantaged Women-Owned Small Business (EDWOSB) set-aside, with the NAICS code 325412 indicating pharmaceutical product manufacturing. The delivery is scheduled for July 17, 2026, to the U.S. Army installation at Fort Campbell, Kentucky, under FOB Destination terms, meaning the contractor assumes all transportation risks until delivery. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, with invoices required to comply with DFARS 252.232-7003 and remitted to the designated P.O. Box. The contract incorporates standard commercial item clauses including representations and certifications, combating trafficking in persons, and contract funding provisions, though no explicit packaging, marking, or preservation standards beyond manufacturer CAGE and NDC codes are detailed. The award was made under a broad-base indefinite-delivery contract with a ceiling value of nearly $20 million, suggesting this order is one of potentially many under the same vehicle. Contract administration is managed by DLA Troop Support personnel, with designated contracting officers and administrative contacts provided, though no Contracting Officer’s Representative is formally appointed. The procurement relies on the Standard Form 1449 structure and references unattached addenda for potential supplemental requirements, leaving certain operational details to be inferred from administrative codes and compliance obligations tied to the EDWOSB status and DPAS-rated order designation.